Cell-Based Assays: World Industry and Market Prospects 2014-2024

世界のセルベースアッセイ(Cell-based Assay)市場(2014-2024)

◆タイトル:Cell-Based Assays: World Industry and Market Prospects 2014-2024
◆商品コード:Visiongain-4052638
◆調査・発行会社:visiongain
◆発行日:2014年3月
◆ページ数:148
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single user licence(1名使用)GBP1,799 ⇒換算¥273,448見積依頼/購入/質問フォーム
Dept Licence(部署内共有可)GBP2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Site Licence(同一国内社内共有可)GBP4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のセルベースアッセイ(Cell-based Assay)市場(2014-2024)"について調査・分析し、エグゼクティブサマリー、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、専門家の見解、主要企業分析、結論などの情報をお届けいたします。

Cellular testing for pharma – new report showing technological trends and sales forecasts
What’s the future of technologies for screening cells? Now you get technological and commercial predictions there from 2014. Stay ahead, then, for data, helping your influence. So you explore developmental trends, sales results, opportunities, and revenue forecasting.
That new study by visiongain shows you what’s possible for cell-based tests and related applications to benefit drug discovery and development. So avoid missing out for pharma R&D tools. Instead find progress there, discovering expected trends, progress and gains.
Read on to explore cell assaying technology, seeing how high its revenues can go.
Forecasts and other analysis showing potential earnings from cell assays
That updated study gives you sales predictions to 2024 at overall world, submarket, and national level. See what the future holds. For those drug discovery and development products you investigate where demand and money lie, seeing potential gains.
There hear what’s possible. And avoid struggles to find information. Besides giving revenue predictions, that new analysis shows recent results, growth rates, and market shares.
So you discover 51 tables, 48 charts, and three interviews with authorities in that industry. There help your research, analyses, and decisions, also benefiting your influence.
And the following sections explain what our new investigation gives you.
Predictions of the cellular assays market and its segments – analyses to help your work
What’s the potential of that biomedical industry? And what’re the secrets of its progress? There find in our report overall world revenue to 2024 for cell assays, with discussions.
Also find individual revenue predictions to 2024 for submarkets there at world level:
• Products
• Services.
And discover further revenue breakdown, to 2024, by application:
• Drug discovery
• ADME (absorption, distribution, metabolism, and excretion), inc. toxicity testing
• Basic research.
There you assess outlooks for sales expansion, hearing where you could gain. That work investigates products, uses, and rising sales. And you find commercial potential.
Our study also explores competition. There you see what’s happening for developers, producers, and sellers of cellular tests, understanding, challenges, trends, and outlooks.
That work also splits its overall world market into geographical revenue predictions.
Sales in leading national markets – what outlooks for medical cell testing?
Also our analyses show you individual revenue forecasts to 2024 for 11 countries:
• United States (US)
• Japan
• Germany, France, UK, Italy, and Spain (EU5), also with an overall EU prediction
• Brazil, Russia, India, and China (BRIC nations).
There you find countries with highest revenues, demand, and potential increases in cell assay use and sales. And you explore competitors, needs, and opportunities. That way you understand trends, progress, and potentials, discovering what gains the future holds.
Also how do events, challenges and advances in technology affect that sector? Our study shows you. It discusses progress, policies, and trends influencing cellular assaying.
Forces affecting developers, producers, and sellers of those drug discovery tools
The report explains issues, operations, and events affecting that industry and market from 2014, including these:
• Drug discovery, validating targets, and lead profiling – including 2D and 3D tests
• Platforms using high throughput screening (HTS) for improved testing efficiency
• Stem cells extending potential for molecular screening, esp. toxicology studies
• Contract research organisations (CROs) in that early-stage drug development.
And you explore these trends and influences, among others:
• Cell assaying equipment, kits, consumables, and disposables
• Detection technology, microplate instrumentation, and flow cytometers, inc. miniaturisation and automation in formats and devices
• High-content screening (HCS) – optimising processes
• R&D spending for pharmaceuticals, with discussions and forecasting.
There you explore what progress, trends and prospects mean. So you discover what benefits and what restricts players in that industry, affecting its results.
Cell technologies for medical product development – top companies and market value
What does the future hold? Our study predicts that world market will reach $6.26bn in 2018.
Also, from 2014, outsourcing of cell-based assay processes will increase. There pharmaceutical clients and CROs will benefit. See how, discovering potentials.
And our new report examines activities of many companies, including these:
• Covance
• Charles River Laboratories
• Sigma-Aldrich
• Thermo Fisher Scientific
• BD Biosciences.
From this decade onwards, the cell assays industry holds many opportunities.
And with those analyses you see how that market can perform, benefiting your reputation for commercial insight.
Ways Cell-Based Assays: World Industry and Market Prospects 2014-2024 helps you
In particular, that new investigation gives you this analysis:
• Revenues there to 2024 at world level and for five submarkets – explore outlooks for production, sales, marketing, and spending
• Forecasts to 2024 for 11 countries in the Americas, Europe, and Asia – assess developed and developing national markets for their predicted revenues
• Prospects for established firms, rising companies, and new entrants – examine product and service portfolios, results, strategies, and outlooks for success.
Information there found nowhere else, benefiting your understanding, work, and authority
Our study gives independent analysis. There you gain competitive intelligence found only in that report, finding where progress and money lie.
So with that data you’re less likely to fall behind in information or miss opportunity. There see how you could save time and effort. And being free to choose, benefit your plans, decisions, and authority, helping you gain competitive advantages.
Knowledge to help your understanding of pharma R&D – benefit from our study now
That new analysis is for everyone exploring pharmaceutical research and development. There, for cell-based assays, you assess trends, results, and revenue forecasts. So avoid missing out – please get that report here now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

【レポートの目次】

1. Executive Summary
1.1 Introducing This New Study
1.2 Cell-Based Assays: World Market Overview to 2024
1.3 Chapter Outlines
1.4 Research and Analysis Methods
1.5 Scope of this Report
2. Introduction to Cell-Based Assays and Applications
2.1 What are Cell-Based Assays?
2.2 Drug Discovery and Development
2.3 Cell-Based Assays Offer Advantages Over Other Assay Types
2.4 2D vs. 3D Cell-Based Assays
2.5 Assay Detection Technology
2.6 Drug Testing Using High-Throughput Screening (HTS)
2.7 Cells Used in Cell-Based Assays
2.7.1 Stem Cells Offer Vast Potential for Drug Screening
3. Cell-Based Assays: World Market 2014-2024
3.1 Overview of the World Cell-Based Assays Market in 2013
3.2 Market Projections for Cell-Based Assays, 2014-2024
3.3 Cell-Based Assays: Market Segmentation, 2013
3.3.1 Leading Cell-Based Assays Products. 2014
3.3.2 The Three Main Categories of Cell-Based Assays Products
3.3.2.1 Equipment to Conduct Cell-Based Assays
3.3.2.2 Disposables Necessary to Perform Cell-Based Assays
3.3.2.3 Consumables Forming the Basis of Cell-Based Assays
3.4 Outsourcing Cell-Based Assays Services
3.4.1 Cell-Based Assay Services: Submarket Revenue Forecast, 2014-2024
3.5 Cell-Based Assays Market Applications
3.5.1 Cell-Based Assays in Drug Discovery Constitute 70% of the Market
3.5.2 ADME-Toxicity Screening (Absorption, Distribution, Metabolism and Excretion)
3.5.3 Basic Research Forms Foundation of Technological Developments
3.6 Total Global R&D Spending Reaches $5.4 Trillion in 2013
3.6.1 Pharma R&D Spending Worth $103bn in 2013
3.6.2 Cell-Based Assays Constitute 3.4% of Pharma R&D Spending
3.6.3 Cell-Based Assays Market: Drivers and Restraints 2014-2024
4. Leading National Markets for Cell Assays 2014-2024
4.1 Regional Breakdown of the World Cell-Based Assays Market, 2013
4.2 World Cell-Based Assays Market: Regional Forecast 2014-2024
4.3 The US Forms the World’s Largest Cell-Based Assays Market
4.4 The Cell-Based Assays Market in the Five Leading European National Markets, 2014-2024
4.4.1 Market Projections for the Leading EU Countries, 2014-2024
4.4.2 EU Breakdown by Country, 2013
4.4.3 Market Projection for the EU Countries, Regional Breakdown 2014-2024
4.4.4 Germany Has a Strong Drug Discovery Base
4.4.5 France’s Drug Discovery Market at Risk
4.4.6 UK Government Promises More Investment in Science Innovation
4.4.7 The Spanish Market Showing Signs of Economic Recovery
4.4.8 Foreign Pharma Giants Dominate the Italian Market
4.5 Japan Has the World’s Second Largest Pharma Market
4.6 The Cell-Based Assays Market in Emerging Countries, Brazil, Russia, India, China (BRIC)
4.6.1 Breakdown of BRIC Nations by Country, 2013
4.6.2 Market Projections for BRIC Countries, 2014-2024
4.6.3 Brazil Flourishing in R&D Spending
4.6.4 Russian Government Invests $4bn in Pharma Industry
4.6.5 Pharma Giants Setting up in India to Reduce Costs
4.6.6 China’s Rapidly Growing Pharmaceutical Market
5. Leading Companies in the Cell-Based Assays Market 2014
5.1 Leading Contract Research Organisations (CROs), 2014
5.1.1 Covance Continues to Dominate the CROs
5.1.2 Charles River Laboratories: Large Player in Early-Stage Drug Development
5.1.3 SGS Offers Specialist Services
5.1.4 Pharmaceutical Product Development (PPD) Recognised for Excellence
5.2 Specialist CROs and Service Companies
5.2.1 Fluofarma’s Specialists in High Content Analysis
5.2.2 Marin Biologic Laboratories Offers Pre-clinical Contract Laboratory Services
5.2.3 MD Biosciences Focuses on Inflammatory, Cardiovascular and Neurological Diseases
5.2.4 ReachBio Shows Primary Cells Are Far More Beneficial
5.2.5 Cell Assay Innovations (CAI) Develop ClariCELL
5.2.6 ProQinase Specialise in Cancer Drug Discovery
5.3 Cell-Based Assays: Product Suppliers
5.3.1 Beckman Coulter: A Leading Diagnostics Company
5.3.2 Sigma-Aldrich: A Principal Contributor to the Life Science Industry
5.3.3 Thermo Fisher Scientific: The World Leader in Serving Science
5.3.3.1 Life Technologies Corporation Acquired by Thermo Fisher Scientific
5.3.4 GE Healthcare Now Offer Stem Cell Models
5.3.5 Promega: A Leading Life Science Product Manufacturer
5.3.6 BD Biosciences Spans Over 50 Countries Worldwide
5.3.7 DiscoveRx Corporation Launch Oncology and Inflammation Primary Cell-Based Platforms
5.3.8 BioVision First to Bring a Cholesterol Detection Cell-Based Assay to the Market
5.3.9 Cisbio Bioassays Partner Up With Pharma Giants, Molecular Devices & Tecan
5.3.10 Cell Biolabs: CytoSelect Platform Allows Fully Quantitative Data
5.3.11 Merck Millipore’s Miniaturised Flow Cytometer Awarded Prize by R&D Magazine
5.3.12 PerkinElmer: A Leading Provider of Technology
5.3.13 BioTek: Specialists of Microplate Instrumentation
6. Cell-Based Assay Technology and Future Outlook 2014-2024
6.1 3D Systems: The Next Generation of Cell Systems
6.2 Toxicity Testing: Animals or Cells?
6.3 Outsourcing Becoming a Phenomenon
6.4 Primary Cells Offer More Potential
6.5 Stem Cells: Tricky Business
6.5.1 Stem Cells in Cell-Based Assays Remain Promising
6.5.2 Many Companies Now Offer Stem Cell Products for the Cell-Based Assay Market
6.5.2.1 STEMCELL Technologies Offer Both iPSCs and ESCs
6.5.3 OncoMed Pharmaceuticals Targeting Cancer Stem Cells
6.6 G-Protein Coupled Receptors (GPCRs)
6.6.1 GPCRs in Cell-Based Assays
6.6.2 Allosteric GPCRs Provide a New Approach
6.7 A Growing Demand for Miniaturisation and Automation
6.8 The Trend towards Robotic Systems
6.9 Microfluidics Can Mimic the In Vivo Environment
6.10 Multiplexing Improves Efficiency of Cell-Based Assays
6.11 Detection Methods in Cell-Based Assays
6.12 High-Content Screening (HCS): A Well Established Tool
6.12.1 Label-Free Systems: A Growing Trend
7. Qualitative Analysis of the Cell-Based Assays Market, 2014-2024
7.1 SWOT Analysis of the Cell-Based Assays Market
7.1.1 Strengths and Weaknesses of the Cell-Based Assays Market in 2014-2024
7.1.2 Opportunities and Threats in the Cell-Based Assay Market, 2014-2024
7.2 STEP Analysis of the Cell-Based Assays Market
7.2.1 Social Developments: Ethical Alternatives to Animal Testing
7.2.2 A High Demand for Technological Advances
7.2.3 Economic Pressures: Budgetary Restraints
7.2.4 Political Issues: Stem Cell Controversy
8. Research Interviews from Our Survey
8.1 Interview with Mr Rob Chaney, General Manager and COO, ReachBio LLC, Seattle, USA
8.1.1 Cell-Based Assays Show Great Potential in Drug Discovery
8.1.2 ReachBio Offer Extensive Cell-Based Assay Services
8.1.3 Why Native Are Cells the Preferential Choice
8.1.4 The Expansion of 3D Systems
8.1.5 Future Projections for Cell-Based Assays
8.2 Interview with Dr Deborah Moshinsky, Founder and President of Cell Assay Innovations, Massachusetts, USA
8.2.1 Cell-Based Assays are Resource Intensive
8.2.2 Cell Assay Innovation’s ClariCELL Technology
8.2.3 The Cell-Based Assays Market is Vast and Diverse
8.3 Interview with Dr Peter Banks, Scientific Director, BioTek Instruments, Vermont, USA
8.3.1 The Dynamic Cell-Based Assays Market
8.3.2 BioTek’s Leading Technology: Cytation™ 3 Cell Imaging Reader
8.3.3 Pluripotent Stem Cells Offer Technological and Commercial Potential
9. Conclusions
9.1 The World Cell-Based Assays Market: Predictions to 2024
9.2 Which Nation will Dominate the Market in 2024?
9.3 The Future of the Cell-Based Assays Industry and Market



List of Tables
Table 2.1 Cell-Based Assays Used in HTS for Drug Screening, 2014
Table 2.2 Types of Cells Available for Drug Screening, 2014
Table 3.1 Cell-Based Assays: Overall World Market Revenue Forecast ($bn, AGR %, CAGR %), 2013-2024
Table 3.2 Cell-Based Assay Submarkets: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.3 Cell-Based Assays Products Submarket: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.4 Cell-Based Assay Services Submarket: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.5 Cell-Based Assays Market Applications: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.6 Drug Discovery Sector: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.7 ADME Sector: Revenue Forecast )$bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.8 Basic Research Sector: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 3.9 Total R&D Spending: Revenues ($bn), Market Shares (%), 2013
Table 3.10 Pharma Global R&D Spending: Revenue Forecast ($bn, AGR %, CAGR %), 2013-2024
Table 3.11 Pharmaceutical R&D Spending Subsectors: Revenues ($bn), Market Shares (%), 2013
Table 3.12 Cell-Based Assays R&D Spending Forecast: Revenues ($bn, AGR %, CAGR %) & Market Shares (%), 2013-2024
Table 4.1 Cell-Based Assays Market Breakdown by Region: Revenues ($bn), Market Shares (%), 2013
Table 4.2 Cell-Based Assays Market Breakdown by Region: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.3 The US Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.4 The EU Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.5 EU Regional Breakdown by Country: Revenues ($bn), Market Shares (%), 2013
Table 4.6 EU Cell-Based Assays Market Breakdown by Country (EU5): Revenue Forecasts ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.7 German Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.8 French Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Shares (%), 2013-2024
Table 4.9 UK Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.10 Spanish Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.11 Italian Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Shares (%), 2013-2024
Table 4.12 Japanese Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.13 BRIC Nations Regional Breakdown by Country: Revenues ($bn), Market Shares (%), 2013
Table 4.14 BRIC Nations Cell-Based Assays Market Breakdown by Region: Revenue Forecast ($bn, AGR % CAGR %) & Market Share (%), 2013-2024
Table 4.15 Brazilian Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Shares (%), 2013-2024
Table 4.16 Russian Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.17 Indian Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 4.18 Chinese Cell-Based Assays Market: Revenue Forecast ($bn, AGR %, CAGR %) & Market Share (%), 2013-2024
Table 5.1 CROs Offering Cell-Based Assay Services, 2014
Table 5.2 Covance Early Development Segment: Revenue Forecast ($bn, AGR %, CAGR %) & Revenue Share (%), 2013-2024
Table 5.3 Charles River Laboratories Pre-Clinical Services: Revenue Forecast ($bn, AGR %, CAGR %) & Revenue Share (%), 2013-2024
Table 5.4 Summary of PPD's Business Segments, 2014
Table 5.5 Danaher: Total Revenues ($bn, %) by Sector, 2013
Table 5.6 Sigma-Aldrich: Total Revenues ($bn, %) by Sector, 2013
Table 5.7 Thermo Fisher Scientific: Revenues ($bn, %) by Sector, 2013
Table 5.8 Thermo Fisher Scientific High Content Analysis Products, 2013
Table 5.9 BD Biosciences: Total Revenues by Sector ($bn, %), 2013
Table 5.10 DiscoveRx's Cell-Based Assay Platforms, 2013
Table 5.11 Cisbio Bioassays Cell-Based Assay Products, 2014
Table 5.12 Merck Millipore: Total Revenues by Sector ($bn, %), 2013
Table 6.1 Selected Companies Offering Stem Cell Assay Systems, 2014
Table 6.2 Selected Companies Offering Label-Free Assay Systems, 2014
Table 7.1 Cell-Based Assays Market: Strengths and Weaknesses, 2014
Table 7.2 Cell-Based Assays Market: Opportunities and Threats, 2014
Table 7.3 Pharmaceutical Outsourcing Market: Revenues ($m) and Market Shares (%), 2013
Table 9.1 Cell-Based Assays Market: Overall Revenue Forecast by Main Division ($bn), & Market Shares (%), 2013, 2018 and 2024
Table 9.2 Cell-Based Assays Regional Markets: Overall Revenue Forecast ($bn) & Market Shares (%), 2013, 2018 and 2024
List of Figures
Figure 3.1 Cell-Based Assays: Overall World Market Revenue Forecast ($bn), 2013-2024
Figure 3.2 Cell-Based Assays Submarket Revenue Forecast ($bn), 2013-2024
Figure 3.3 Cell-Based Assays Products Submarket: Revenue Forecast ($bn), 2013-2024
Figure 3.4 Cell-Based Assay Products: Market Model, 2014
Figure 3.5 Cell-Based Assay Services: Submarket Revenues ($bn), 2013-2024
Figure 3.6 Cell-Based Assays Market Applications: Revenue Forecast ($bn), 2013-2024
Figure 3.7 Drug Discovery Sector: Revenues ($bn), 2013-2024
Figure 3.8 ADME Sector: Market Revenue Forecast ($bn), 2013-2024
Figure 3.9 Basic Research Sector: Revenue Forecast ($bn), 2013-2024
Figure 3.10 Main R&D Spending Subsectors, Market Shares (%), 2013
Figure 3.11 Pharma Global R&D Spending, Revenue Forecast ($bn), 2013-2024
Figure 3.12 Cell-Based Assays R&D Spending: Revenues ($bn), 2013
Figure 3.13 Cell-Based Assays R&D Spending Forecast: Revenues ($bn), 2013-2024
Figure 3.14 Pharmaceutical vs. Cell-Based Assay R&D Spending Shares (%), 2018
Figure 3.15 Pharmaceutical vs. Cell-Based Assay R&D Spending Shares (%), 2024
Figure 3.16 Global Cell-Based Assays Market: Drivers and Restraints, 2014-2024
Figure 4.1 Cell-Based Assays Market Breakdown by Region, Revenues ($bn) & Market Shares (%), 2013
Figure 4.2 Cell-Based Assays Market Breakdown by Region: Revenue Forecast ($bn), 2013-2024
Figure 4.3 The US Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.4 The EU Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.5 EU Regional Breakdown by Country: Revenues ($bn), Market Shares (%), 2013
Figure 4.6 EU Regional Breakdown by Country (EU5): Revenue Forecast ($bn), 2013-2024
Figure 4.7 German Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.8 French Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.9 UK Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.10 Spanish Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.11 Italian Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.12 Japanese Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.13 BRIC Nations: Regional Breakdown by Country, Revenues ($bn), Market Shares (%), 2013
Figure 4.14 BRIC Nations Regional Breakdown by Country: Revenue Forecast ($bn), 2013-2024
Figure 4.15 Brazilian Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.16 Russian Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.17 Indian Cell-Based Assays Market: Revenue Forecast ($bn), 2013-2024
Figure 4.18 Chinese Cell-Based Assays Market: Revenue Forecast($m), 2013-2024
Figure 5.1 Covance Revenue Forecast by Segment, 2013-2024
Figure 5.2 Covance Early Development Segment: Revenue Forecast ($bn), 2013-2024
Figure 5.3 Charles River Laboratories: Revenue Shares by Segment, 2013
Figure 5.4 Charles River Laboratories: Revenue Forecast by Segment, 2012-2024
Figure 5.5 Charles River Laboratories Pre-Clinical Services: Revenue Forecast ($bn), 2013-2024
Figure 5.6 Danaher: Revenue Shares ($bn, %) by Sector, 2013
Figure 5.7 Sigma-Aldrich: Revenue Shares ($bn, %) by Sector, 2013
Figure 5.8 Thermo Fisher Scientific: Revenue Shares ($bn, %) by Sector, 2013
Figure 5.9 BD Biosciences: Revenue Shares by Sector ($bn, %), 2013
Figure 5.10 Merck Millipore: Revenue Shares by Sector ($bn, %), 2013
Figure 5.11 Perkin Elmer: Revenue Shares by Sector ($bn, %), 2013
Figure 7.1 Pharmaceutical Outsourcing Market Shares (%), 2013
Figure 9.1 Cell-Based Assays Market: Overall Revenue Forecasts by Main Division ($bn), 2013, 2018 and 2024
Figure 9.2 Cell-Based Assays Regional Market: Overall Revenues ($bn) in 2013, 2018 and 2024


【掲載企業】

Amsbio
Applied Biosystems
Apredica
Assay Services
Aurelia Bioscience
AvantiCell Science
Axiogenesis
Bayer Pharma AG
BD Biosciences
Beckman Coulter
Biocroi
BioFocus
Bionas
BioSeek
BioSpherix
Biotechnology & Biological Sciences Research Council (BBSRC)
BioTek
BioTime
BioVision
BMG Labtech
Boehringer Mannheim
Caliper Life Science
Celgene Corporation
Cell Assay Innovations (CAI)
Cell Biolabs
Cell Systems 3-D
Cellomics
Cellular Dynamics International
Charles River Laboratories
Cisbio Bioassays
Codex Biosolutions
Contract Research Organisation (CRO)
Corning
Covance
Cyprotex
Danaher
Di Carlo Laboratory
DiscoveRx
Dr. Reddy's Laboratories
EMD Millipore
ESI Bio
European Cell-based Assays Interest Group (EuCAI)
European Collection of Cell Cultures (ECACC)
Evotec
Experimental Therapeutics Centre
Fluofarma
ForteBio
GE Healthcare
Genentech
General Electric
GlaxoSmithKline
Innovative Medicines Initiative (IMI)
International Stem Cell Corporation (ISCO)
Invitrogen (part of Life Technologies)
Invivo Sciences
Johnson & Johnson
Jubilant Biosys
LabCorp
Labcyte
Life Technologies
Marin Biologic Laboratories
MD Biosciences
Medical Research Council (MRC)
Merck & Co.
Merck KGaA
Midas Mediscience
Molecular Devices
MultiCell Technologies
NeoStem
Novartis
OncoMed Pharmaceuticals
PCL Alverno Clinical Laboratories
Perkin Elmer
Pfizer
Pharmaron
PPD
Premas Biotech
Primorigen Biosciences
Princeton University
Promega
ProQinase
Puracyp
ReachBio
Reaction Biology Corporation
ReNeuron
Roche
Seahorse Bioscience
SGS
Sigma-Aldrich
SRU Biosystems
Stem Cell Innovations
STEMCELL Technologies
SymCel
Tecan
The HUB Foundation for Organoid Technology
Thermo Fisher Scientific
Trinity College Dublin
University of California, Los Angeles (UCLA)
US Food & Drug Administration (FDA)
Vitro Biopharma
World Trade Organization (WTO)


★調査レポート[世界のセルベースアッセイ(Cell-based Assay)市場(2014-2024)] ( Cell-Based Assays: World Industry and Market Prospects 2014-2024 / Visiongain-4052638) 販売に関する免責事項
[世界のセルベースアッセイ(Cell-based Assay)市場(2014-2024)] ( Cell-Based Assays: World Industry and Market Prospects 2014-2024 / Visiongain-4052638) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆